Prestige Consumer Healthcare (PBH) Acquisitions (2010 - 2022)
Prestige Consumer Healthcare (PBH) posted quarterly Acquisitions of $132000.0 for Q1 2022, down 99.27% quarter-over-quarter from $18.0 million in Q4 2021.
Prestige Consumer Healthcare (PBH) Acquisitions (2010 - 2022) Analysis & Trends
Prestige Consumer Healthcare's Acquisitions history runs 8 years deep, the most recent figure standing at $132000.0 for Q1 2022.
- In Q1 2022, Acquisitions changed N/A year-over-year to $132000.0; the TTM figure through Mar 2023 stood at $18.1 million (changed 0.0% YoY), while the FY2022 annual figure was $247.0 million, changed N/A from the prior year.
- Acquisitions for Q1 2022 stood at $132000.0, down from $18.0 million in the prior quarter.
- The five-year high for Acquisitions was $18.0 million in Q4 2021, with the low at $132000.0 in Q1 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Acquisitions (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | - |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Prestige Consumer Healthcare | 2.46 Bn | 2.39 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2022 | 132,000.00 |
| Dec 31, 2021 | 18.00 Mn |
| Jun 30, 2017 | 970,000.00 |
| Mar 31, 2017 | -1.40 Mn |
| Dec 31, 2016 | 1.40 Mn |
| Mar 31, 2016 | 226.98 Mn |
| Dec 31, 2014 | -77.99 Mn |
| Jun 30, 2014 | 77.99 Mn |
| Mar 31, 2012 | 661.60 Mn |
| Mar 31, 2011 | -202.04 Mn |
| Dec 31, 2010 | 202.04 Mn |